1.	Phase III Combination Chemotherapy with ADR, CTX, VCR, CACP, VP-16, CCNU, PCB, MTX plus Radiotherapy with/without Thymosin for Limited and Extensive Small Cell Carcinoma of the Lung Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MSKCC-7891R
2.	Phase III Randomized Trial of Thymosin-Alpha-1 Following Radiotherapy for Limited, Nonresectable non-Small Cell Carcinoma of the Lung Phase: Phase III Type: Treatment Status: Completed Age: 18 to 74 Sponsor: NCI Protocol IDs: RTOG-8321, RTOG-83-21
3.	Phase III Sequential CMC (CTX/MTX/CCNU) and VAP (VCR/ADR/PCB) with/without Radiotherapy in Limited, Inoperable Small Cell Lung Carcinoma (Summary last modified 06/97) Phase: Phase III Type: Treatment Status: Completed Age: no age specified Sponsor: NCI Protocol IDs: NCI-78-C-19A, NCI-NMOB-813, NCI-T83-1461N, T83-1461
4.	Phase III Radiotherapy with or without Thymosin-alpha-1 for Patients with Locally Advanced Nonbulky Unresectable and Postsurgical Residual non-Small Cell Lung Cancer Phase: Phase III Type: Treatment Status: Closed Age: 18 and over Sponsor: Protocol IDs: MAOP-2283
5.	Phase III Chemotherapy with CTX/ADR/VCR/ARA-C/PRED with or without Thymosin for Chronic Lymphocytic Leukemia Phase: Phase III Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MDA-DT-7971, NCI-V84-0020
6.	A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: Ta1-HCC-2K1001, NCT00082082
7.	Chemotherapy with FACP (Ftorafur/ADR/CTX/CACP) with or without Immunotherapy with Thymosin for non-Oat Cell Carcinoma of the Lung Phase: No phase specified Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MDA-DT-7653A
8.	Chemotherapy with FACP (Ftorafur/ADR/CTX/CACP) with or without Thymosin or Intravenous Hyperalimentation for Lung Cancer Phase: No phase specified Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MDA-DT-7751
9.	Chemotherapy with FACP (FT/ADR/CTX/CACP) with and without Thymosin Immunotherapy for Metastatic Squamous Cell Lung Carcinoma Phase: No phase specified Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MDA-DT-7752
10.	VAP (DAVA/ADR/CACP) Chemotherapy with/without Thymosin for Metastatic Disseminated non-Oat Cell Lung Carcinoma Phase: No phase specified Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MDA-DT-7902
11.	Adjuvant Chemotherapy and Immunotherapy with DTIC, Thymosin and BCG for Patients with Surgically Cured Recurrent Melanoma Phase: No phase specified Type: Treatment Status: Completed Age: no age specified Sponsor: Protocol IDs: MDA-DT-7561
12.	CTX/ADR/VCR Induction with Added CCNU/MTX/PCB or CTX/VCR plus Radiotherapy Consolidation for Small Cell Lung Cancer Phase: No phase specified Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MSKCC-7891
13.	Phase II Immunotherapy with Thymosin Fraction 5 as a Single Agent in Nonresectable Metastatic or Recurrent Prostatic Carcinoma and Metastatic Renal Cancer Phase: No phase specified Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: NCOG-4P821, NCOG-4P-82-1
14.	Adjuvant Thymosin/TAA Immunotherapy, Radiotherapy, plus MTX Chemotherapy for Stage II Regional Epidermoid Lung Cancer Phase: No phase specified Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: PCCC-PU-7612
15.	Chemotherapy with ADR/CACP/Ftorafur plus Immunotherapy with Thymosin for Metastatic Adenocarcinoma and Large Cell Carcinoma of the Lung Phase: No phase specified Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MDA-DT-7653
16.	CACP or CACP/BLEO/MTX with or without Thymosin Immunotherapy for Advanced Head and Neck Cancer and Genitourinary Tumors Phase: No phase specified Type: Treatment Status: Closed Age: no age specified Sponsor: Protocol IDs: MDA-DT-7664